BioFed Funds is passionate about helping start-ups and emerging biopharma companies with creative ways to generate revenue. For companies largely dependent on venture capital, offering innovative strategies to achieve additional revenue options to lengthen the cash runway in today's capital-raising environment is paramount to a company's success.
BioFed Funds has partnered with Jorns & Associates to assist the emerging biopharma company in qualifying and receiving their Employee Retention Credit (ERC) from the U.S. Treasury. The ERC opportunity can be a supplementary and profoundly impactful fundraising approach to produce extra revenue quickly for emerging biopharma.
Marc Bencivenga, Principal & Founder
Marc is an accomplished biotech executive with strong experience in biotech start-up strategic leadership, Business Development & Licensing and medicinal chemistry. He is passionate about bringing strategic focus and establishing a balanced team of experienced executives to execute the optimal value creating strategy. During 20 years with innovative R&D based life sciences companies, Marc has built a broad experience in pharmaceutical discovery and development, in many therapeutic areas. Marc has held executive management positions in several companies within the Unities States and Europe.
Our Partner
ERC Program Featured In
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.